{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:54:13Z","timestamp":1794405253862,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":88,"publisher":"Humana Press","isbn-type":[{"value":"9781617794292","type":"print"},{"value":"9781617794308","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T00:00:00Z","timestamp":1317254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T00:00:00Z","timestamp":1317254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-61779-430-8_1","type":"book-chapter","created":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T17:37:52Z","timestamp":1322501872000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Mammalian Target of Rapamycin: A Signaling Kinase for Every Aspect of Cellular Life"],"prefix":"10.1007","author":[{"given":"Thomas","family":"Weichhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,29]]},"reference":[{"key":"1_CR1_1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/cr.2007.64","volume":"17","author":"Q Yang","year":"2007","unstructured":"Yang, Q., and Guan, K. L. (2007) Expanding mTOR signaling. Cell Res\n                17, 666\u201381.","journal-title":"Cell Res"},{"key":"1_CR2_1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","volume":"14","author":"RT Abraham","year":"1996","unstructured":"Abraham, R. T., and Wiederrecht, G. J. (1996) Immunopharmacology of rapamycin. Annu Rev Immunol\n                14, 483\u2013510.","journal-title":"Annu Rev Immunol"},{"key":"1_CR3_1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol\n                12, 21\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1_CR4_1","doi-asserted-by":"publisher","first-page":"E592","DOI":"10.1152\/ajpendo.90645.2008","volume":"296","author":"J Avruch","year":"2009","unstructured":"Avruch, J., Long, X., Ortiz-Vega, S., Rapley, J., Papageorgiou, A., and Dai, N. (2009) Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab\n                296, E592\u2013602.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1_CR5_1","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1002\/eji.200737281","volume":"37","author":"AC Donahue","year":"2007","unstructured":"Donahue, A. C., and Fruman, D. A. (2007) Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur J Immunol\n                37, 2923\u201336.","journal-title":"Eur J Immunol"},{"key":"1_CR6_1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ni.1645","volume":"9","author":"W Cao","year":"2008","unstructured":"Cao, W., Manicassamy, S., Tang, H., Kasturi, S. P., Pirani, A., Murthy, N., et al. (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol\n                9, 1157\u201364.","journal-title":"Nat Immunol"},{"key":"1_CR7_1","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1002\/eji.200838761","volume":"38","author":"F Schmitz","year":"2008","unstructured":"Schmitz, F., Heit, A., Dreher, S., Eisenacher, K., Mages, J., Haas, T., et al. (2008) Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol\n                38, 2981\u201392.","journal-title":"Eur J Immunol"},{"key":"1_CR8_1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","volume":"29","author":"T Weichhart","year":"2008","unstructured":"Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., et al. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity\n                29, 565\u201377.","journal-title":"Immunity"},{"key":"1_CR9_1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1042\/BST0320315","volume":"32","author":"DA Fruman","year":"2004","unstructured":"Fruman, D. A. (2004) Towards an understanding of isoform specificity in phosphoinositide 3-kinase signalling in lymphocytes. Biochem Soc Trans\n                32, 315\u20139.","journal-title":"Biochem Soc Trans"},{"key":"1_CR10_1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","volume":"11","author":"DA Guertin","year":"2005","unstructured":"Guertin, D. A., and Sabatini, D. M. (2005) An expanding role for mTOR in cancer. Trends Mol Med\n                11, 353\u201361.","journal-title":"Trends Mol Med"},{"key":"1_CR11_1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2004.03.006","volume":"29","author":"DP Brazil","year":"2004","unstructured":"Brazil, D. P., Yang, Z. Z., and Hemmings, B. A. (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci\n                29, 233\u201342.","journal-title":"Trends Biochem Sci"},{"key":"1_CR12_1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.immunol.22.012703.104721","volume":"22","author":"JA Deane","year":"2004","unstructured":"Deane, J. A., and Fruman, D. A. (2004) Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol\n                22, 563\u201398.","journal-title":"Annu Rev Immunol"},{"key":"1_CR13_1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1056\/NEJMe0707153","volume":"358","author":"E Paul","year":"2008","unstructured":"Paul, E., and Thiele, E. (2008) Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis. N Engl J Med\n                358, 190\u20132.","journal-title":"N Engl J Med"},{"key":"1_CR14_1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ncb995","volume":"5","author":"H Stocker","year":"2003","unstructured":"Stocker, H., Radimerski, T., Schindelholz, B., Wittwer, F., Belawat, P., Daram, P., et al. (2003) Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol\n                5, 559\u201365.","journal-title":"Nat Cell Biol"},{"key":"1_CR15_1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ncb1753","volume":"10","author":"E Kim","year":"2008","unstructured":"Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., and Guan, K. L. (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol\n                10, 935\u201345.","journal-title":"Nat Cell Biol"},{"key":"1_CR16_1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., and Sabatini, D. M. (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell\n                141, 290\u2013303.","journal-title":"Cell"},{"key":"1_CR17_1","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., et al. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science\n                320, 1496\u2013501.","journal-title":"Science"},{"key":"1_CR18_1","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay, N., and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev\n                18, 1926\u201345.","journal-title":"Genes Dev"},{"key":"1_CR19_1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-3-642-18930-2_15","volume":"279","author":"DH Kim","year":"2004","unstructured":"Kim, D. H., and Sabatini, D. M. (2004) Raptor and mTOR: subunits of a nutrient-sensitive complex. Curr Top Microbiol Immunol\n                279, 259\u201370.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR20_1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1356-9597.2004.00727.x","volume":"9","author":"N Oshiro","year":"2004","unstructured":"Oshiro, N., Yoshino, K., Hidayat, S., Tokunaga, C., Hara, K., Eguchi, S., et al. (2004) Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells\n                9, 359\u201366.","journal-title":"Genes Cells"},{"key":"1_CR21_1","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M. A., Hall, A., et al. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol\n                6, 1122\u20138.","journal-title":"Nat Cell Biol"},{"key":"1_CR22_1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2011.02.014","volume":"144","author":"V Zinzalla","year":"2011","unstructured":"Zinzalla, V., Stracka, D., Oppliger, W., and Hall, M. N. (2011) Activation of mTORC2 by Association with the Ribosome. Cell\n                144, 757\u201368.","journal-title":"Cell"},{"key":"1_CR23_1","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/emboj.2010.271","volume":"29","author":"WJ Oh","year":"2010","unstructured":"Oh, W. J., Wu, C. C., Kim, S. J., Facchinetti, V., Julien, L. A., Finlan, M., et al. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J\n                29, 3939\u201351.","journal-title":"EMBO J"},{"key":"1_CR24_1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science\n                307, 1098\u2013101.","journal-title":"Science"},{"key":"1_CR25_1","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J. Huang","year":"2008","unstructured":"Huang, J., Dibble, C. C., Matsuzaki, M., and Manning, B. D. (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol\n                28, 4104\u201315.","journal-title":"Mol Cell Biol"},{"key":"1_CR26_1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"D dos Sarbassov","year":"2006","unstructured":"Sarbassov dos, D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell\n                22, 159\u201368.","journal-title":"Mol Cell"},{"key":"1_CR27_1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","volume":"658","author":"M Rosner","year":"2008","unstructured":"Rosner, M., Hanneder, M., Siegel, N., Valli, A., and Hengstschlager, M. (2008) The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat Res\n                658, 234\u201346.","journal-title":"Mutat Res"},{"key":"1_CR28_1","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/hmg\/ddn192","volume":"17","author":"M. Rosner","year":"2008","unstructured":"Rosner, M., and Hengstschlager, M. (2008) Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalisation of the mTORC2 components rictor and sin1. Hum Mol Genet\n                17, 2934\u201348.","journal-title":"Hum Mol Genet"},{"key":"1_CR29_1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1126\/science.1187532","volume":"328","author":"RJ Dowling","year":"2010","unstructured":"Dowling, R. J., Topisirovic, I., Alain, T., Bidinosti, M., Fonseca, B. D., Petroulakis, E., et al. (2010) mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science\n                328, 1172\u20136.","journal-title":"Science"},{"key":"1_CR30_1","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/S0021-9258(18)53755-8","volume":"268","author":"WG Morice","year":"1993","unstructured":"Morice, W. G., Brunn, G. J., Wiederrecht, G., Siekierka, J. J., and Abraham, R. T. (1993) Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1\/S-phase growth arrest in T lymphocytes. J Biol Chem\n                268, 3734\u20138.","journal-title":"J Biol Chem"},{"key":"1_CR31_1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/372570a0","volume":"372","author":"J Nourse","year":"1994","unstructured":"Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., et al. (1994) Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature\n                372, 570\u20133.","journal-title":"Nature"},{"key":"1_CR32_1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.molcel.2008.04.027","volume":"30","author":"F Hong","year":"2008","unstructured":"Hong, F., Larrea, M. D., Doughty, C., Kwiatkowski, D. J., Squillace, R., and Slingerland, J. M. (2008) mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell\n                30, 701\u201311.","journal-title":"Mol Cell"},{"key":"1_CR33_1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/hmg\/ddm103","volume":"16","author":"M Rosner","year":"2007","unstructured":"Rosner, M., Freilinger, A., Hanneder, M., Fujita, N., Lubec, G., Tsuruo, T., et al. (2007) p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet\n                16, 1541\u201356.","journal-title":"Hum Mol Genet"},{"key":"1_CR34_1","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.273.7.3963","volume":"273","author":"T Noda","year":"1998","unstructured":"Noda, T., and Ohsumi, Y. (1998) Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem\n                273, 3963\u20136.","journal-title":"J Biol Chem"},{"key":"1_CR35_1","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1091\/mbc.E08-12-1249","volume":"20","author":"CH Jung","year":"2009","unstructured":"Jung, C. H., Jun, C. B., Ro, S. H., Kim, Y. M., Otto, N. M., Cao, J., et al. (2009) ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell\n                20, 1992\u20132003.","journal-title":"Mol Biol Cell"},{"key":"1_CR36_1","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1128\/MCB.24.21.9508-9516.2004","volume":"24","author":"YG Gangloff","year":"2004","unstructured":"Gangloff, Y. G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J. F., et al. (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol\n                24, 9508\u201316.","journal-title":"Mol Cell Biol"},{"key":"1_CR37_1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2172-10-28","volume":"10","author":"B Shor","year":"2009","unstructured":"Shor, B., Cavender, D., and Harris, C. (2009) A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice. BMC Immunol\n                10, 28.","journal-title":"BMC Immunol"},{"key":"1_CR38_1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/MCB.00985-10","volume":"31","author":"S. M. Goorden","year":"2011","unstructured":"Goorden, S. M., Hoogeveen-Westerveld, M., Cheng, C., van Woerden, G. M., Mozaffari, M., Post, L., et al. (2011) Rheb is essential for murine development. Mol Cell Biol\n                31, 1672\u20138.","journal-title":"Mol Cell Biol"},{"key":"1_CR39_1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.devcel.2010.11.020","volume":"20","author":"J Zou","year":"2011","unstructured":"Zou, J., Zhou, L., Du, X. X., Ji, Y., Xu, J., Tian, J., et al. (2011) Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell\n                20, 97\u2013108.","journal-title":"Dev Cell"},{"key":"1_CR40_1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1432-2277.2009.01041.x","volume":"23","author":"M Haidinger","year":"2010","unstructured":"Haidinger, M., Hecking, M., Weichhart, T., Poglitsch, M., Enkner, W., Vonbank, K., et al. (2010) Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int\n                23, 777\u201385.","journal-title":"Transpl Int"},{"key":"1_CR41_1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nn.2477","volume":"13","author":"D Nie","year":"2010","unstructured":"Nie, D., Di Nardo, A., Han, J. M., Baharanyi, H., Kramvis, I., Huynh, T., et al. (2010) Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat Neurosci\n                13, 163\u201372.","journal-title":"Nat Neurosci"},{"key":"1_CR42_1","doi-asserted-by":"publisher","first-page":"28034","DOI":"10.1074\/jbc.M110.125336","volume":"285","author":"N Abe","year":"2010","unstructured":"Abe, N., Borson, S. H., Gambello, M. J., Wang, F., and Cavalli, V. (2010) Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves. J Biol Chem\n                285, 28034\u201343.","journal-title":"J Biol Chem"},{"key":"1_CR43_1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1126\/science.1161566","volume":"322","author":"KK Park","year":"2008","unstructured":"Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., et al. (2008) Promoting axon regeneration in the adult CNS by modulation of the PTEN\/mTOR pathway. Science\n                322, 963\u20136.","journal-title":"Science"},{"key":"1_CR44_1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.201006094","volume":"191","author":"D Li","year":"2010","unstructured":"Li, D., Zhou, J., Wang, L., Shin, M. E., Su, P., Lei, X., et al. (2010) Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions. J Cell Biol\n                191, 631\u201344.","journal-title":"J Cell Biol"},{"key":"1_CR45_1","doi-asserted-by":"publisher","first-page":"7840","DOI":"10.1073\/pnas.0901854106","volume":"106","author":"J Zhou","year":"2009","unstructured":"Zhou, J., Su, P., Wang, L., Chen, J., Zimmermann, M., Genbacev, O., et al. (2009) mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci USA\n                106, 7840\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR46_1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/scd.2009.0147","volume":"19","author":"KW Lee","year":"2010","unstructured":"Lee, K. W., Yook, J. Y., Son, M. Y., Kim, M. J., Koo, D. B., Han, Y. M., et al. (2010) Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP\/Smad pathway. Stem Cells Dev\n                19, 557\u201368.","journal-title":"Stem Cells Dev"},{"key":"1_CR47_1","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1093\/hmg\/ddq236","volume":"19","author":"N Siegel","year":"2010","unstructured":"Siegel, N., Rosner, M., Unbekandt, M., Fuchs, C., Slabina, N., Dolznig, H., et al. (2010) Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet\n                19, 3320\u201331.","journal-title":"Hum Mol Genet"},{"key":"1_CR48_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/cell.2010.0011","volume":"12","author":"CAt Easley","year":"2010","unstructured":"Easley. C.A.t., Ben-Yehudah. A., Redinger. C.J., Oliver. S.L., Varum. S.T., Eisinger. V.M., et al., (2010). mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. Cell Reprogram. 12, 263\u201373.","journal-title":"Cell Reprogram"},{"key":"1_CR49_1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature04703","volume":"441","author":"OH Yilmaz","year":"2006","unstructured":"Yilmaz, O. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., et al. (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature\n                441, 475\u201382.","journal-title":"Nature"},{"key":"1_CR50_1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cell.2010.06.041","volume":"142","author":"RM Hobbs","year":"2010","unstructured":"Hobbs, R. M., Seandel, M., Falciatori, I., Rafii, S., and Pandolfi, P. P. (2010) Plzf regulates germline progenitor self-renewal by opposing mTORC1. Cell\n                142, 468\u201379.","journal-title":"Cell"},{"issue":"Suppl 4","key":"1_CR51_1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1463-1326.2008.00952.x","volume":"10","author":"G Leibowitz","year":"2008","unstructured":"Leibowitz, G., Cerasi, E., and Ketzinel-Gilad, M. (2008) The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes. Diabetes Obes Metab\n                10 Suppl 4, 157\u201369.","journal-title":"Diabetes Obes Metab"},{"key":"1_CR52_1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/ajpendo.00262.2009","volume":"297","author":"H. Mori","year":"2009","unstructured":"Mori, H., Inoki, K., Opland, D., Muenzberg, H., Villanueva, E. C., Faouzi, M., et al. (2009) Critical roles for the TSC-mTOR pathway in {beta}-cell function. Am J Physiol Endocrinol Metab\n                297, 1013\u201322.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1_CR53_1","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1073\/pnas.131202998","volume":"98","author":"CA Janeway Jr","year":"2001","unstructured":"Janeway, C. A., Jr. (2001) How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci USA\n                98, 7461\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR54_1","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1600-6143.2009.02832.x","volume":"9","author":"MD Saemann","year":"2009","unstructured":"Saemann, M. D., Haidinger, M., Hecking, M., Horl, W. H., and Weichhart, T. (2009) The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant\n                9, 2655\u201361.","journal-title":"Am J Transplant"},{"key":"1_CR55_1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.it.2009.02.002","volume":"30","author":"T Weichhart","year":"2009","unstructured":"Weichhart, T., and Saemann, M. D. (2009) The multiple facets of mTOR in immunity. Trends Immunol\n                30, 218\u201326.","journal-title":"Trends Immunol"},{"key":"1_CR56_1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1462-5822.2006.00699.x","volume":"8","author":"CS Yang","year":"2006","unstructured":"Yang, C. S., Song, C. H., Lee, J. S., Jung, S. B., Oh, J. H., Park, J., et al. (2006) Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin\/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages. Cell Microbiol\n                8, 1158\u201371.","journal-title":"Cell Microbiol"},{"key":"1_CR57_1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1182\/blood-2008-02-137430","volume":"112","author":"M Ohtani","year":"2008","unstructured":"Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., et al. (2008) Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood\n                112, 635\u201343.","journal-title":"Blood"},{"key":"1_CR58_1","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/j.1600-6143.2010.03302.x","volume":"10","author":"S. Brouard","year":"2010","unstructured":"Brouard, S., Puig-Pey, I., Lozano, J. J., Pallier, A., Braud, C., Giral, M., et al. (2010) Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients under Cyclosporin A or Sirolimus Monotherapy. Am J Transplant\n                10, 2604\u201314.","journal-title":"Am J Transplant"},{"key":"1_CR59_1","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.4049\/jimmunol.1000296","volume":"185","author":"M Haidinger","year":"2010","unstructured":"Haidinger, M., Poglitsch, M., Geyeregger, R., Kasturi, S., Zeyda, M., Zlabinger, G. J., et al. (2010) A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol\n                185, 3919\u201331.","journal-title":"J Immunol"},{"key":"1_CR60_1","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood-2010-09-310888","volume":"117","author":"T. Weichhart","year":"2011","unstructured":"Weichhart, T., Haidinger, M., Katholnig, M., Kopecky, C., Poglitsch, M., Lassnig, C., et al. (2011) Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood\n                117, 4273\u201383.","journal-title":"Blood"},{"key":"1_CR61_1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nm.2157","volume":"16","author":"T Yoshida","year":"2010","unstructured":"Yoshida, T., Mett, I., Bhunia, A. K., Bowman, J., Perez, M., Zhang, L., et al. (2010) Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med\n                16, 767\u201373.","journal-title":"Nat Med"},{"key":"1_CR62_1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nm.1928","volume":"15","author":"C Jagannath","year":"2009","unstructured":"Jagannath, C., Lindsey, D. R., Dhandayuthapani, S., Xu, Y., Hunter, R. L., Jr., and Eissa, N. T. (2009) Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med\n                15, 267\u201376.","journal-title":"Nat Med"},{"key":"1_CR63_1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ni1141","volume":"5","author":"M Colonna","year":"2004","unstructured":"Colonna, M., Trinchieri, G., and Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol\n                5, 1219\u201326.","journal-title":"Nat Immunol"},{"key":"1_CR64_1","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1074\/jbc.M607365200","volume":"282","author":"S Kaur","year":"2007","unstructured":"Kaur, S., Lal, L., Sassano, A., Majchrzak-Kita, B., Srikanth, M., Baker, D. P., et al. (2007) Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J Biol Chem\n                282, 1757\u201368.","journal-title":"J Biol Chem"},{"key":"1_CR65_1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature06730","volume":"452","author":"R Colina","year":"2008","unstructured":"Colina, R., Costa-Mattioli, M., Dowling, R. J., Jaramillo, M., Tai, L. H., Breitbach, C. J., et al. (2008) Translational control of the innate immune response through IRF-7. Nature\n                452, 323\u20138.","journal-title":"Nature"},{"key":"1_CR66_1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu, J., Yamane, H., and Paul, W. E. (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol\n                28, 445\u201389.","journal-title":"Annu Rev Immunol"},{"key":"1_CR67_1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"GM Delgoffe","year":"2009","unstructured":"Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., et al. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity\n                30, 832\u201344.","journal-title":"Immunity"},{"key":"1_CR68_1","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","volume":"105","author":"M Battaglia","year":"2005","unstructured":"Battaglia, M., Stabilini, A., and Roncarolo, M. G. (2005) Rapamycin selectively expands CD4 \u2009+ \u2009CD25 \u2009+ \u2009FoxP3+ regulatory T cells. Blood\n                105, 4743\u20138.","journal-title":"Blood"},{"key":"1_CR69_1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.immuni.2010.06.002","volume":"32","author":"K. Lee","year":"2010","unstructured":"Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N., et al. (2010) Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity\n                32, 743\u201353.","journal-title":"Immunity"},{"key":"1_CR70_1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.immuni.2010.06.008","volume":"32","author":"T Weichhart","year":"2010","unstructured":"Weichhart, T., and Saemann, M. D. (2010) T helper cell differentiation: understanding the needs of hierarchy. Immunity\n                32, 727\u20139.","journal-title":"Immunity"},{"key":"1_CR71_1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ni.1603","volume":"9","author":"LV Sinclair","year":"2008","unstructured":"Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., et al. (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol\n                9, 513\u201321.","journal-title":"Nat Immunol"},{"key":"1_CR72_1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","volume":"460","author":"K Araki","year":"2009","unstructured":"Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., et al. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature\n                460, 108\u201312.","journal-title":"Nature"},{"key":"1_CR73_1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L. S., et al. (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature\n                460, 103\u20137.","journal-title":"Nature"},{"key":"1_CR74_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.18632\/aging.100070","volume":"1","author":"SL Hands","year":"2009","unstructured":"Hands, S. L., Proud, C. G., and Wyttenbach, A. (2009) mTOR\u2019s role in ageing: protein synthesis or autophagy? Aging (Albany NY)\n                1, 586\u201397.","journal-title":"Aging (Albany NY)"},{"key":"1_CR75_1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature\n                460, 392\u20135.","journal-title":"Nature"},{"key":"1_CR76_1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.1173635","volume":"325","author":"RJ Colman","year":"2009","unstructured":"Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., et al. (2009) Caloric restriction delays disease onset and mortality in rhesus monkeys. Science\n                325, 201\u20134.","journal-title":"Science"},{"key":"1_CR77_1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1126\/science.1177221","volume":"326","author":"C Selman","year":"2009","unstructured":"Selman, C., Tullet, J. M., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., et al. (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science\n                326, 140\u20134.","journal-title":"Science"},{"key":"1_CR78_1","first-page":"2177","volume":"56","author":"JL Miller","year":"1999","unstructured":"Miller, J. L. (1999) Sirolimus approved with renal transplant indication. Am J Health Syst Pharm\n                56, 2177\u20138.","journal-title":"Am J Health Syst Pharm"},{"key":"1_CR79_1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O\u2019Shaughnessy, C., et al. (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med\n                349, 1315\u201323.","journal-title":"N Engl J Med"},{"key":"1_CR80_1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd2062","volume":"5","author":"S Faivre","year":"2006","unstructured":"Faivre, S., Kroemer, G., and Raymond, E. (2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov\n                5, 671\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR81_1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler, J. J., McCormack, F. X., Young, L. R., Elwing, J. M., Chuck, G., Leonard, J. M., et al. (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med\n                358, 140\u201351.","journal-title":"N Engl J Med"},{"key":"1_CR82_1","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., et al. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem\n                284, 8023\u201332.","journal-title":"J Biol Chem"},{"key":"1_CR83_1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4161\/auto.5.5.8504","volume":"5","author":"CC Thoreen","year":"2009","unstructured":"Thoreen, C. C., and Sabatini, D. M. (2009) Rapamycin inhibits mTORC1, but not completely. Autophagy\n                5, 725\u20136.","journal-title":"Autophagy"},{"key":"1_CR84_1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1158\/0008-5472.CAN-09-2340","volume":"70","author":"K Yu","year":"2010","unstructured":"Yu, K., Shi, C., Toral-Barza, L., Lucas, J., Shor, B., Kim, J. E., et al. (2010) Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Res\n                70, 621\u201331.","journal-title":"Cancer Res"},{"key":"1_CR85_1","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1158\/0008-5472.CAN-09-0299","volume":"69","author":"K Yu","year":"2009","unstructured":"Yu, K., Toral-Barza, L., Shi, C., Zhang, W. G., Lucas, J., Shor, B., et al. (2009) Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res\n                69, 6232\u201340.","journal-title":"Cancer Res"},{"key":"1_CR86_1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","volume":"70","author":"CM Chresta","year":"2010","unstructured":"Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., et al. (2010) AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res\n                70, 288\u201398.","journal-title":"Cancer Res"},{"key":"1_CR87_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.18632\/oncotarget.110","volume":"1","author":"MR Janes","year":"2010","unstructured":"Janes, M. R., and Fruman, D. A. (2010) Targeting TOR dependence in cancer. Oncotarget\n                1, 69\u201376.","journal-title":"Oncotarget"},{"key":"1_CR88_1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm.2091","volume":"16","author":"MR Janes","year":"2010","unstructured":"Janes, M. R., Limon, J. J., So, L., Chen, J., Lim, R. J., Chavez, M. A., et al. (2010) Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor. Nat Med\n                16, 205\u201313.","journal-title":"Nat Med"}],"container-title":["Methods in Molecular Biology","mTOR"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-430-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:24:24Z","timestamp":1675077864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-61779-430-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,29]]},"ISBN":["9781617794292","9781617794308"],"references-count":88,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-430-8_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-61779-430-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,29]]},"assertion":[{"value":"29 September 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}